Safety Alerts - 2015

Archives

See below for past years:

2016 |  2015 |  2014 |  2013 |  2012

Gardasil vaccine safety studies show no new risks

December 11, 2015

After reviewing Canadian and international information regarding the safety of the HPV vaccine Gardasil, Health Canada is informing Canadians that the benefits of using this vaccine continue to outweigh the risks. The overall evidence continues to demonstrate that this vaccine can be safely used and that there are no new safety risks associated with its use.

Update by Sanofi Canada on Nationwide Voluntary Recall of Allerject

December 2, 2015

Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada Inc. (Sanofi Canada) of all lots of Allerject® epinephrine auto-injectors of both the 0.15mg/0.15mL and 0.30mg/0.3mL strengths, and given the recent announcement that stock of alternative epinephrine auto-injectors is now sufficient to replace all Allerject® devices in Canada, Sanofi Canada is notifying the public of the following updates:

Sanofi Canada Issues Voluntary Nationwide Recall Of Allerject

October 28, 2015

Sanofi-aventis Canada Inc. (Sanofi Canada) is recalling all Allerject® (epinephrine injection, USP). The voluntary recall involves all Allerject currently on the market and includes both the 0.15 mg/ 0.15 mL and 0.3 mg/0.3 mL strengths for hospitals, retailers and consumers. The products have been found to potentially have inaccurate dosage delivery. If a patient who is experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis is a potentially life-threatening condition.